Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Feb;56(1):17-28.
doi: 10.1007/s13139-021-00728-0. Epub 2022 Jan 24.

KSNM60 in Nuclear Endocrinology: from the Beginning to the Future

Chae Moon Hong #  1 , Young Jin Jeong #  2 , Hae Won Kim #  3 , Byeong-Cheol Ahn  1
Affiliations
Review

KSNM60 in Nuclear Endocrinology: from the Beginning to the Future

Chae Moon Hong et al. Nucl Med Mol Imaging. 2022 Feb.

Abstract

Nuclear endocrinology is the main ignitor for founding the Korean Society of Nuclear Medicine (KSNM) in the early 1960s by outstanding pioneering medical doctors. Management of thyroid diseases required nuclear medicine technology in the early days of the KSNM and was rapidly developed by advancements in nuclear medicine technology. Nuclear thyroidology remains one of the main clinical applications in nuclear medicine worldwide. Nuclear medicine technology provides essential information for diagnosing and assessing diseases of the parathyroid glands, pituitary gland, and neuroendocrine tumors (NETs). In addition, therapeutic nuclear medicine is essential for managing nonresectable NETs. Nuclear endocrinology remains a major section in clinical nuclear medicine, and members of the KSNM have contributed to progressing better management of benign and malignant endocrine diseases. This review summarizes the historical activities and milestone contributions to nuclear endocrinology made by the members of the KSNM over the past 60 years to congratulate the KSNM on its 60-year anniversary.

Keywords: Neuroendocrine tumor; Nuclear endocrinology; Parathyroid gland; Pituitary gland; Thyroid gland.

PubMed Disclaimer

Conflict of interest statement

Competing InterestsChae Moon Hong, Young Jin Jeong, Hae Won Kim, and Byeong-Cheol Ahn declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
Radioactive iodine uptake measurement in the 1960s
Fig. 2
Fig. 2
a Image acquisition of a thyroid gland with a dot scanner in the 1970s and b thyroid scintigraphic images
Fig. 3
Fig. 3
Numbers of patients receiving radioiodine therapy and incidences of newly diagnosed thyroid cancer
Fig. 4
Fig. 4
Ten-year anniversary of the Thyroid Study Group of the Korean Society of Nuclear Medicine
Fig. 5
Fig. 5
Radioimmunoassay in the 1970s
Fig. 6
Fig. 6
Number of nuclear medicine imaging tests for neuroendocrine tumors in Korea over the past 8 years. MIBG, metaiodobenzylguanidine; PET, positron emission tomography
Fig. 7
Fig. 7
Number of radionuclide therapy for neuroendocrine tumors in Korea. MIBG, metaiodobenzylguanidine
See this image and copyright information in PMC

References

    1. 50 Year Department of Nuclear Medicine Seoul National University. 2010.
    1. Toh SH. Thyroid and radioactive I131. J Korean Med Assoc. 1961;4:72–83.
    1. Chun MH, Kim YS, Suh DS, Bae SH, Hong SC, Toh SH. A long follow-up study on Graves’ disease after I131 Treatment. Korean J Med. 1969;12:641–647.
    1. Cho BY, Koh CS. Current trends in the diagnosis and treatment of Graves’ disease in Korea. Endocrinol Metab. 1992;7:216–227.
    1. Moon JH, Yi KH. The diagnosis and management of hyperthyroidism in Korea: consensus report of the Korean Thyroid Association. Endocrinol Metab (Seoul) 2013;28:275–279. - PMC - PubMed

LinkOut - more resources